Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy

NCT05523869 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Interventions

DRUG: Intravitreal topotecan
PROCEDURE: Pars plana vitrectomy with or without scleral buckle

Sponsor

Unity Health Toronto